Raymond Cheong
Director/Board Member chez TALIS BIOMEDICAL CORPORATION
Fortune : - $ au 31/03/2024
Profil
Dr. Raymond Cheong is on the Board of Directors at vTv Therapeutics, Inc., Madrigal Pharmaceuticals, Inc., Talis Biomedical Corp.
and Istari Oncology, Inc. Dr. Cheong also served on the board at Talis Biomedical Corp.
He received his undergraduate degree from the University of Maryland and a doctorate degree from The Johns Hopkins University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
TALIS BIOMEDICAL CORP.
-.--% | 31/01/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Raymond Cheong
| Sociétés | Poste | Début |
|---|---|---|
| TALIS BIOMEDICAL CORPORATION | Director/Board Member | 10/03/2023 |
| MADRIGAL PHARMACEUTICALS, INC. | Director/Board Member | 15/06/2023 |
| VTV THERAPEUTICS INC. | Director/Board Member | 27/02/2024 |
Istari Oncology, Inc.
 Istari Oncology, Inc. BiotechnologyHealth Technology Istari Oncology, Inc. operates as a clinical-stage biotechnology company. It focuses on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. Its core technology assets are PVS-RIPO, a prototypic oncolytic recombinant polio virus vaccine, and a series of antibody-drug conjugates comprising antibodies or antibody fragments to a variety of oncology targets. The company was founded by Darell D. Bigner and Matthias Gromeier in 2016 and is headquartered in Research Triangle Park, NC. | Director/Board Member | 01/12/2018 |
Anciens postes connus de Raymond Cheong
| Sociétés | Poste | Fin |
|---|---|---|
| TALIS BIOMEDICAL CORPORATION | Director/Board Member | 10/06/2022 |
Formation de Raymond Cheong
| The Johns Hopkins University | Doctorate Degree |
| University of Maryland | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| VTV THERAPEUTICS INC. | Health Technology |
| MADRIGAL PHARMACEUTICALS, INC. | Health Technology |
| TALIS BIOMEDICAL CORPORATION | Health Technology |
| Entreprise privées | 1 |
|---|---|
Istari Oncology, Inc.
Istari Oncology, Inc. BiotechnologyHealth Technology Istari Oncology, Inc. operates as a clinical-stage biotechnology company. It focuses on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. Its core technology assets are PVS-RIPO, a prototypic oncolytic recombinant polio virus vaccine, and a series of antibody-drug conjugates comprising antibodies or antibody fragments to a variety of oncology targets. The company was founded by Darell D. Bigner and Matthias Gromeier in 2016 and is headquartered in Research Triangle Park, NC. | Health Technology |
